Adjuvant checkpoint inhibitor trials: Is disease-free survival an appropriate endpoint?
File(s)Adjuvant Commentary_v8_tracked.docx (43 KB)
Accepted version
Author(s)
Khaki, Ali Raza
Lythgoe, Mark P
Prasad, Vinay
Type
Journal Article
Date Issued
2023-01-11
Date Acceptance
2023-01-08
Citation
Journal of Cancer Policy, 2023, 35, pp.1-2
ISSN
2213-5383
Publisher
Elsevier
Start Page
1
End Page
2
Journal / Book Title
Journal of Cancer Policy
Volume
35
Copyright Statement
Copyright © 2023 Elsevier Ltd. All rights reserved. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/36639103
PII: S2213-5383(23)00019-X
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2023-01-11